Corporate Executives
Director
Akira Kurokawa
Representative Director of the Board, Chairman
- Corporate Management
- Life science business
- Understanding medical field and patients
Takeshi Ito
Representative Director of the Board, President and Chief Executive Officer
- Life science business
- Understanding medical field and patients
Kanoko Oishi
Director of the Board※
- Corporate management
- Understanding medical field and patients
- ESG and service to society
Yutaro Shintaku
Director of the Board※
- Corporate management
- Life science business
- Global leadership
Kunihito Minakawa
Director of the Board※
- Global leadership
- Finance and accounting
- Legal affairs and risk control
Noboru Kotani
Director of the Board※
- Corporate management
- Life science business
Tamie Minami
Director of the Board※
- Life science business
- Global leadership
- Outside Directors are independent officers as designed by the Tokyo Stock Exchange.
Corporate Auditor
Hiroshi Isaka
Standing Corporate Auditor
- Life science business
- Understanding medical field and patients
Hirofumi Yasuhara
Outside Auditor※
- Corporate management
- Global leadership
- Finance and accounting
Yumiko Ito
Outside Auditor※
- Global leadership
- Legal affairs and risk control
- ESG and service to society
Masahiko Ikaga
Outside Auditor※
- Corporate management
- Finance and accounting
- Legal affairs and risk control
- Outside Auditor are independent officers as designed by the Tokyo Stock Exchange.
Among skills respectively held, two or at most three skills, which are specifically advantageous or those with strong relevance to the businesses of Santen, are described.
- Corporate management
- Life science business
- Understanding medical field and patients
- Global leadership
- Finance and accounting
- Legal affairs and risk control
- ESG and service to society
Executive Management Team / Corporate Officers
Executive Management Team
| Chief Operating Officer | Rie Nakajima |
| Head of Asia Business | Jozica Grenz |
| Head of EMEA Business, Head of North America Business | Luis Iglesias |
| Head of Japan Business, Head of Japan Sales and Marketing Division, Head of Marketing Department | Ippei Kurihara |
| Head of China Business | Takayuki Yamada |
| Global Head, Cell & Gene Business Segment | Marianthi Psacha |
| Global Head, Medical Tech Solutions Business Segment | Robert Wagner |
| Head of Ophthalmology Innovation Center | Reza Haque |
| Chief Medical Officer | Peter Sallstig |
| Chief Product Supply Officer | Mark Dawson |
| Chief Digital & Information Officer | Minori Hara |
| Chief Communications Officer | Nobuko Kato |
| Chief Financial Officer & Chief Risk Officer | Kazuo Koshiji |
| Deputy Chief Financial Officer | Sheila Li |
| General Counsel & Chief Compliance Officer | Mika Masunari |
| Chief Business Officer | Chris Reindel |
Corporate Officers
| Head of Sales Department, Japan Sales and Marketing Division | Shinichi Teramachi |
| Head of Supply Chain Division | Frank Binder |
| Global Head of Business Development, Strategy | Ken Araki |
| Global Head of Core Principle & People Centricity, HR, Sustainability & Administration | Takahiro Morita |
Official SNS
